Results 221 to 230 of about 40,707 (252)

A Silent Threat in Post-Tuberculosis Patients: Chronic Pulmonary Aspergillosis Survey in Multiple Regions of Indonesia (I-CHROME Study). [PDF]

J Fungi (Basel)
Rozaliyani A, Setianingrum F, Isbaniah F, Agustin H, Handayani RRD, Syahrir R, Pratiekauri S, Adawiyah R, Setiastuti H, Erhamza MN, Soemarwoto RAS, Medison I, Herman D, Pratama AD, Apridasari J, Jane J, Soedarsono S, Kusmiati T, Hasanah M, Adhyaksanti D, Sofvina W, Hasyim AA, Kosmidis C, Denning DW.   +23 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Invasive pulmonary aspergillosis

Revista Clínica Española (English Edition), 2020
AbstractInvasive pulmonary aspergillosis (IPA) remains difficult to diagnose and to treat. Most common risk factors are prolonged neutropenia, hematopoietic stem cell or solid organ transplantation, inherited or acquired immunodeficiency, administration of steroids or other immunosuppressive agents including monoclonal antibodies and new small ...
L.A. Fernández-Bermejo, G. Ramírez-Olivencia   +1 more
openaire   +6 more sources

Invasive Pulmonary Aspergillosis

Respiration, 2002
<i>Background:</i> Invasive pulmonary aspergillosis usually occurs in immunocompromised patients. Mild abnormality of host defence is usually present in the chronic necrotising form of the disease. Acute aspergillus pneumonia usually affects patients who are seriously immunocompromised.
Ema Mušič, Izidor Kern, Sabina Škrgat Kristan   +2 more
openaire   +5 more sources

Pulmonary aspergillosis

The Netherlands Journal of Medicine, 2001
Aspergillus species are ubiquitous in the environment and are inevitably inhaled into the airways. Inhalation of Aspergillus conidia or mycelium fragments may result in colonisation of the airways. In susceptible hosts colonisation may subsequently cause disease.
J F, Tomee, T S, van der Werf
openaire   +2 more sources

Invasive pulmonary aspergillosis

Expert Review of Anti-infective Therapy, 2005
In susceptible patients, invasive aspergillosis has a high incidence and a mortality of up to 80%. The diagnosis of this condition is difficult, especially in the early stages of the disease and, as a consequence, antifungal therapy, despite its expense and toxicity, is often initiated empirically.
Sarah R. Doffman, Samir G. Agrawal, Jeremy S. Brown   +2 more
openaire   +5 more sources